Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects. [electronic resource]
Producer: 19980618Description: 17F-24F p. digitalISSN:- 0002-9149
- Animals
- Clofibrate -- pharmacology
- Drug Evaluation -- methods
- Drug Evaluation, Preclinical
- Drugs, Investigational -- pharmacology
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Hyperlipidemias -- drug therapy
- Hypolipidemic Agents -- pharmacology
- Legislation, Drug
- Probucol -- pharmacology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.